Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
3 results
Active substance : alemtuzumab
Topics : Economics and public health
Language : Français
OK
Chercher
Filter
Topic
Economics and public health
(3)
Plus ...
Organisation of care
(1)
Health economics
(1)
Screening, prevention
(1)
Diseases and conditions
(3)
Plus ...
Immune system diseases
(2)
Plus ...
Autoimmune diseases
(1)
Immunologic deficiency syndromes
(1)
Nervous system diseases
(1)
Plus ...
Central nervous system diseases
(1)
Demyelinating diseases
(1)
Cancers - miscellaneous
(1)
Genital diseases
(1)
Plus ...
Female genital diseases
(1)
Genital cancers
(1)
Diagnostic and therapeutic techniques
(2)
Plus ...
Drug therapy
(2)
Content type
Practice Guidelines and Other Guides
(2)
Plus ...
Practice guidelines
(1)
Public Health guideline
(1)
Drugs, devices and medical acts
(1)
Plus ...
Medicine
(1)
Date
This month
(1)
Fabricant
industriels
(1)
Langue
Français
(3)
Substance active
acide folique
(1)
alemtuzumab
(3)
azathioprine
(1)
chlorure de sodium
(1)
ciprofloxacine
(1)
cisplatine
(1)
cyclophosphamide
(1)
gemcitabine
(1)
ifosfamide
(1)
oxaliplatine
(1)
paclitaxel
(1)
pentostatine
(1)
rituximab
(1)
trastuzumab
(1)
More filter
Save your search
Search Export
Practice guidelines and other guides
- 2 results
Cervical cancer screening in immunosuppressed persons (other than PLHIV)
Public Health guideline
- Posted on 8/10/2025
Add to
my selection
Patient selection criteria for at-home cancer chemotherapy
Practice guidelines
- Posted on 1/9/2003 - Mis à jour le 30/10/2006
Download
abstract
Add to
my selection
Drugs, devices and medical acts
- 1 result
LEMTRADA
Medicine
- Posted on 25/10/2018 - Mis à jour le 12/6/2019
Add to
my selection
Français
English
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
Cq0ckuEUaYDenxmK